MONDAY, Jan. 6, 2025 -- Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood...
Vous n'êtes pas connecté
THURSDAY, Jan. 2, 2025 -- Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes, including small for gestational age, according to a study published in the January issue of The...
MONDAY, Jan. 6, 2025 -- Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood...
THURSDAY, Dec. 26, 2024 -- Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcomes in...
THURSDAY, Dec. 26, 2024 -- COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability,...
FRIDAY, Jan. 3, 2025 -- For pediatric patients with Crohn disease, early anti-tumor necrosis factor-alpha (anti-TNFα) therapy is beneficial in...
FRIDAY, Jan. 3, 2025 -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical...
FRIDAY, Jan. 3, 2025 -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical...
MONDAY, Jan 6, 2025 -- Turns out, starting physical therapy earlier after a concussion may significantly improve recovery outcomes. A new study...
MONDAY, Jan 6, 2025 -- Turns out, starting physical therapy earlier after a concussion may significantly improve recovery outcomes. A new study...
FRIDAY, Dec. 27, 2024 -- Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within five years before...
TUESDAY, Jan. 7, 2025 -- Childhood exposure to school segregation is associated with worse late-life cognitive outcomes among older Black adults,...